Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathology [Corrigendum]

Abstract

El-kady AM, Ahmad AA, Hassan TM, et al. Infect Drug Resist. 2019;12:709–719.On page 709 in the abstract, in the Materials and methods section should read “The murine model of S. mansoni was established in four groups of adult male Balb-c mice; group I (infected non-treated group), groups II and III (infected groups) treated orally with eugenol and praziquantel(PZQ), respectively and group IV (non-infected non treated group). The expression of the sensitive immunohistochemical marker α-smooth muscle actin (α-SMA) in schistosome-infected tissues was determined. In addition, parasitological, biochemical, and histological parameters that reflect disease severity and morbidity were examined.”Read the original article.